<DOC>
	<DOC>NCT01108757</DOC>
	<brief_summary>The study will assess the risk of catheter associated urinary tract infection in women undergoing incontinence or reconstructive pelvic surgery. Women will be given an antibiotic or placebo at the time of catheter removal. The investigators hypothesize that prophylactic antibiotics will reduce the rate of infection.</brief_summary>
	<brief_title>Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Trimethoprim, Sulfamethoxazole Drug Combination</mesh_term>
	<criteria>Requires catheterization &gt;24h hours following incontinence or pelvic reconstructive surgery Receipt of antibiotics for either prophylaxis or treatment of a known infection during the postoperative hospitalization Allergy to sulfonamides or trimethoprim NonEnglish speaking Pregnancy Breast feeding Severe renal impairment (creatinine clearance &lt;30) Patients taking dofetilide, methenamine, procaine, warfarin, procainamide, methotrexate.</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>catheter</keyword>
	<keyword>urinary tract infection</keyword>
</DOC>